Showing results (141-150 of 6,492) with videos related to
Sort By:
Pageof 650
Clinical Pharmacokinetics|November 15, 2001
Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorderJ S Markowitz, K S PatrickNeurosurgery|May 1, 1984
Feasibility of intracranial surgery in the rat fetus: model and surgical principlesR A Brodner, R S MarkowitzPsychopharmacology Bulletin|October 26, 2002
Psychoactive drug interactions with pharmacotherapy for diabetesC Lindsay DeVane, John S MarkowitzPsychopharmacology Bulletin|October 26, 2002
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum)J S Markowitz, C L DeVaneBulletin of the Menninger Clinic|March 1, 2000
Avoiding psychotropic drug interactions in the cardiovascular patientC L DeVane, J S MarkowitzCurrent Opinion in Nephrology and Hypertension|April 18, 2009
Classification of lupus nephritisGlen S Markowitz, Vivette D D'AgatiDrug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2008
Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variantsHao-Jie Zhu, John S MarkowitzExpert Opinion on Drug Metabolism & Toxicology|July 15, 2014
A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorderJohn S Markowitz, Bryan J BrindaJournal of Clinical Psychopharmacology|June 18, 2008
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?John S Markowitz, Kennerly S PatrickPageof 650